Create Medic Co., Ltd.
TSE:5187.T
902 (JPY) • At close November 8, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) JPY.
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue
| 12,585.449 | 12,257.294 | 11,698.682 | 10,830.471 | 10,843.961 | 10,796.964 | 10,393.563 | 10,003.003 | 9,650.702 | 9,939.799 | 9,880.617 | 9,331.915 | 9,325.368 | 9,097.359 | 9,017.696 | 9,058.88 |
Cost of Revenue
| 7,107.109 | 6,882.779 | 6,438.464 | 5,752.701 | 5,615.683 | 5,753.127 | 5,471.262 | 5,499.962 | 5,438.977 | 5,684.431 | 5,502.229 | 5,025.799 | 4,822.444 | 4,484.119 | 4,414.043 | 4,359.556 |
Gross Profit
| 5,478.34 | 5,374.515 | 5,260.218 | 5,077.77 | 5,228.278 | 5,043.837 | 4,922.301 | 4,503.041 | 4,211.725 | 4,255.368 | 4,378.388 | 4,306.116 | 4,502.924 | 4,613.24 | 4,603.653 | 4,699.324 |
Gross Profit Ratio
| 0.435 | 0.438 | 0.45 | 0.469 | 0.482 | 0.467 | 0.474 | 0.45 | 0.436 | 0.428 | 0.443 | 0.461 | 0.483 | 0.507 | 0.511 | 0.519 |
Reseach & Development Expenses
| 850 | 882.093 | 785.74 | 630.241 | 637.198 | 616.612 | 506.151 | 362.922 | 281.326 | 250 | 285 | 358 | 0 | 0 | 0 | 0 |
General & Administrative Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Selling & Marketing Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
SG&A
| 3,825.096 | 3,754.71 | 3,607.693 | 3,462.707 | 3,507.651 | 3,433.365 | 3,562.144 | 3,385.841 | 3,282.241 | 3,471 | 3,553 | 3,566 | 0 | 0 | 0 | 0 |
Other Expenses
| 23.51 | 4,636.803 | 4,393.433 | 4,092.948 | 4,144.849 | 12.58 | 18.103 | 13.039 | 15.851 | 13.862 | 23.552 | 52.381 | 2.537 | 16.631 | 7.588 | 33.806 |
Operating Expenses
| 4,675.096 | 4,636.803 | 4,393.433 | 4,092.948 | 4,144.849 | 4,049.977 | 4,068.295 | 3,748.763 | 3,563.566 | 3,471.14 | 3,553.734 | 3,566.349 | 3,501.612 | 3,382.12 | 3,326.406 | 3,265.758 |
Operating Income
| 803.244 | 737.711 | 866.784 | 984.821 | 1,083.427 | 993.859 | 854.006 | 754.277 | 648.158 | 784.227 | 824.654 | 739.765 | 1,001.311 | 1,231.12 | 1,277.246 | 1,433.565 |
Operating Income Ratio
| 0.064 | 0.06 | 0.074 | 0.091 | 0.1 | 0.092 | 0.082 | 0.075 | 0.067 | 0.079 | 0.083 | 0.079 | 0.107 | 0.135 | 0.142 | 0.158 |
Total Other Income Expenses Net
| 100.78 | 99.031 | 98.842 | -0.432 | 18.152 | -13.691 | -84.61 | 53.165 | -28.904 | 43.259 | 70.216 | 178.73 | 51.053 | -116.33 | -175.281 | -118.609 |
Income Before Tax
| 904.024 | 836.742 | 965.626 | 984.389 | 1,101.579 | 980.168 | 769.396 | 807.443 | 619.255 | 827.487 | 894.87 | 918.497 | 1,052.365 | 1,114.79 | 1,101.966 | 1,314.957 |
Income Before Tax Ratio
| 0.072 | 0.068 | 0.083 | 0.091 | 0.102 | 0.091 | 0.074 | 0.081 | 0.064 | 0.083 | 0.091 | 0.098 | 0.113 | 0.123 | 0.122 | 0.145 |
Income Tax Expense
| 750.001 | 376.096 | 305.217 | 324.866 | 376.525 | 307.631 | 301.434 | 290.748 | 286.111 | 337.427 | 361.241 | 406.225 | 468.983 | 447.248 | 476.469 | 504.63 |
Net Income
| 154.022 | 482.213 | 660.409 | 659.523 | 725.054 | 672.536 | 467.961 | 516.695 | 333.143 | 490.059 | 533.628 | 512.271 | 583.382 | 667.541 | 625.496 | 810.326 |
Net Income Ratio
| 0.012 | 0.039 | 0.056 | 0.061 | 0.067 | 0.062 | 0.045 | 0.052 | 0.035 | 0.049 | 0.054 | 0.055 | 0.063 | 0.073 | 0.069 | 0.089 |
EPS
| 16.92 | 53 | 72.61 | 71.19 | 77.83 | 72.2 | 50.23 | 54.73 | 34.64 | 50.96 | 55.49 | 53.27 | 60.66 | 69.41 | 65.04 | 84.26 |
EPS Diluted
| 16.92 | 53 | 72.61 | 71.19 | 77.83 | 72.2 | 50.23 | 54.73 | 34.64 | 50.96 | 55.49 | 53.27 | 60.66 | 69.41 | 65.04 | 84.26 |
EBITDA
| 1,391.392 | 1,418.235 | 1,484.118 | 1,372.382 | 1,464.81 | 1,349.36 | 1,240.715 | 1,166.155 | 986.803 | 1,364.823 | 1,274.475 | 1,210.896 | 1,232.438 | 1,353.574 | 1,520.925 | 1,621.812 |
EBITDA Ratio
| 0.111 | 0.116 | 0.127 | 0.127 | 0.135 | 0.125 | 0.119 | 0.117 | 0.102 | 0.137 | 0.129 | 0.13 | 0.132 | 0.149 | 0.169 | 0.179 |